What sector is TLSI in?

TriSalus Life Sciences, Inc. Common Stock (TLSI) operates in the Technology sector, specifically in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.

What is TLSI's market cap?

TriSalus Life Sciences, Inc. Common Stock (TLSI) has a market capitalization of $276M.

How can I analyze TLSI stock?

Valhalla provides comprehensive analysis for TLSI including institutional trade flow, dark pool activity, options data, technical indicators, and proprietary scoring. Visit valhalla-labs.io/stocks/TLSI for a full breakdown.

Where can I find institutional trades for TLSI?

Valhalla tracks real-time institutional trade flow for TLSI, including dark pool blocks, lit block trades, and sweep orders. These insights help identify where smart money is positioned.

TLSI

Q: What is TLSI (TriSalus Life Sciences, Inc. Common Stock)?

TriSalus Life Sciences, Inc. Common Stock (TLSI) is a technology company in the surgical & medical instruments & apparatus industry. TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors. The company offers the TriNav Infusion System

TriSalus Life Sciences, Inc. Common Stock

Technology — SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Valhalla Score 43

$4.38

TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors. The company offers the TriNav Infusion System for hepatic arterial infusion of liver tumors; and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors. It also develops SD-101, an investigational immunotherapeutic with pressure-enabled drug delivery technology for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company is based in Westminster, Colorado.

Latest News

TriSalus Life Sciences to Host First Quarter 2026 Financial Results Conference CallWESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of care therapies, and its inv...businesswire.com — Apr 28, 2026

TLSI Data Insights

Dark pool activity detected in the last 5 trading days

Subscribe for full dark pool analysis, institutional flow, and real-time alerts.

📊 Key Statistics

Market Cap$276M

P/E Ratio—

EPS (TTM)—

EPS YoY—

Revenue YoY—

Float—

Short Float %—

Inst. Ownership—

Sector RS—

📈 Fundamentals

ROE—

ROIC—

ROA—

Current Ratio—

Debt/Equity—

Gross Margin—

Net Margin—

Dividend Yield—

Next Earnings—

⚡ Options Summary

Call OI—

Put OI—

P/C Ratio (OI)—

Gamma Environment—

Max Pain—

Call Wall—

Put Wall—

🎯 Analyst Estimates

Consensus Target—

High Target—

Low Target—

Analysts—

Upside/Downside—

📋 Quarterly Financials

Period	Revenue	Rev YoY	EPS	EPS YoY	Gross Margin

Start Free Trial See full options flow, dark pool data & more

🔥 Recent Options Flow

Type	Strike	Exp	Size	Premium	Time

Start Free Trial Institutional trades, dark pool vs lit exchange

🏛️ Institutional Trades

Type	Price	Size	Value	Venue	Time

Start Free Trial Full insider & congressional trade history

👤 Insider Trades

Name	Type	Shares	Price	Date

Start Free Trial Top institutional holders & ownership data

🏦 Top Institutional Holders

Institution	Shares	Value	% of Class